Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen is finding tractable hits/leads for your pharmaceutical relevant targets, using three proprietary 2nd and 3rd generation DEL technologies.
Vipergen is offering different business models, including simple Fee-For-Service. Vipergen is offering different business models, including simple Fee-F...
Vipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies. Vipergen is finding tractable hits/leads for your pharmaceutical relevant targets, using three proprietary 2nd and 3rd generation DEL technologies.
Vipergen is offering different business models, including simple Fee-For-Service. Vipergen is offering different business models, including simple Fee-For-Service. In 2015-20 >40 deals signed, including with top-5 pharma in both USA, EU and Japan. The company is privately owned by Gunnar Kjems and Dr. Nils Hansen incorporated in Copenhagen, Denmark
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.